Dr Tony Leachon named DOH 'special adviser' | Inquirer

Dr Tony Leachon named DOH ‘special adviser’

/ 11:52 AM August 11, 2023

Dr Tony Leachon is named DOH Special Adviser for Non-Communicable Diseases

Tony Leachon. SCREENGRAB from Dr. Tony Leachon’s Facebook page

MANILA, Philippines — Department of Health (DOH) Secretary Teodoro Herbosa Jr. has appointed Dr. Anthony “Tony” Leachon as the agency’s Special Adviser for Non-Communicable Diseases.

Herbosa said Leachon, an internist and a cardiologist, will greatly help the agency in its reforms and initiatives.

FEATURED STORIES

“With the aid of Dr. Leachon, we will ensure that Bawat Pilipino, ramdam ang kalusugan dahil sa Healthy Pilipinas, bawat buhay mahalaga (Every Filipino feels healthy because with a Healthy Pilipinas, every life is important),” Herbosa said in a statement posted Friday on the DOH’s official Facebook page.

Leachon was a special adviser to the National Task Force against COVID-19 in 2020, during the term of President Rodrigo Duterte.

Article continues after this advertisement

But he resigned, citing differences with DOH policies and its alleged lack of urgency and management at the height of the pandemic.

Article continues after this advertisement

“I left NTF due to my differences with DOH policies e.g., Lack of sense of urgency, problems in COVID data management, and transparency in the communication process. That’s life. That’s how it is. There’s a silver lining, though. Thank you very much,” Leachon said in a tweet on June 2020.

RELATED STORY

Año says he regrets Leachon’s removal from NTF

kga/abc
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

pop
usa
business
sports
business
TAGS: DoH, Health, Tony Leachon

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.